Skip to content

Monitoring Antioxidant/Redox Status at Concordia (MARS-C)

Monitoring Antioxidant/Redox Status and Replenishing Nitrogen & Sulfur-based Nutrients to Enhance Resilience at Concordia (MARS-C): Understanding Integrated Stress Signalling

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04197193
Acronym
MARS-C
Enrollment
30
Registered
2019-12-13
Start date
2022-10-03
Completion date
2024-12-31
Last updated
2024-01-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oxidative Stress

Brief summary

The European Space Agency (ESA) runs a research centre in Antarctica as an earth-based model for long duration deep-space missions. Just like astronauts travelling into space, crew-members overwintering at this Concordia base are exposed to a number of extreme environmental stressors; including high altitude (approximately 3800m); extreme cold; long periods of 24 hour darkness or daylight; and complete isolation. The investigators will recruit up to 30 over-wintering crew members working at this station for ESA over a 2 year period and observe how their bodies adapt and respond to the stress of living and working in this environment. The investigators will collect blood, saliva and urine samples, together with ultrasound images of muscle mass and grip strength measurements at regular intervals throughout their deployment to Antarctica. These samples will be transported back to Southampton to be analysed for biochemical levels of stress. During the final month of their stay, all participants will be randomised to receive a daily nutritional drink which is either high or low in targeted dietary supplements. Following similar studies that the investigators has successfully performed over shorter durations at high altitudes previously, they hypothesise that levels of stress experienced in extreme environments such as Antarctica or deep space can be reduced with targeted nutritional supplementation. These findings may become important to members of the general public as commercial aviation moves increasingly towards using low space-orbital vehicles to drastically reduce international travel times over the coming decade.

Interventions

None listed

Sponsors

European Space Agency
CollaboratorOTHER
University of Southampton
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Adult * Member of Concordia station over-wintering crew * Able to give written informed consent * Fluent in either English, French or Italian

Exclusion criteria

* Participating in another interventional research study during the deployment to Concordia

Design outcomes

Primary

MeasureTime frameDescription
Hand grip strengthup to 10 monthsForearm muscle / grip strength recorded non-invasively using a hand grip dynamometer

Secondary

MeasureTime frameDescription
Muscle massup to 10 monthscross sectional forearm muscle area recorded a standardised way using medical ultrasound
Oxidative stressup to 10 monthsNitrate, nitrite, nitroso species, FRAP, TFTs, glutathione ratios, 8-isoprostane,
Lake Louise Score 2018up to 10 monthsA validated measure of altitude related symptoms and illness which scores symptoms across 4 different domains: headache, GI disturbance, fatigue & dizziness. Each is scored from 0 - 3 (for no symptoms to very debilitating respectively) and a total score of 3 or more including at headache symptoms is required for a positive diagnosis of Acute Mountain Sickness

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026